Cyprus vs United States: Coverage of the human papillomavirus vaccine
Cyprus
67
in 2025
United States
66
in 2025
Cyprus rank
45th
United States rank
48th
Coverage of the human papillomavirus vaccine over time
- Cyprus
- United States
How they compare
Cyprus currently reports 67 against 66 in United States, a difference of 1.
The two have swapped places 1 time across 8 shared years of data; in 2018 it was United States ahead.
Cyprus ranks 45th and United States ranks 48th of 85 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.5 | 58.5 | 2 | United States |
| 2020s | 65.5 | 66.33 | 0.8333 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Cyprus or United States?
- Cyprus, at 67 against 66 in United States as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Cyprus and United States?
- 1, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and United States?
- 8 years are reported by both, from 2018 to 2025.
- How do Cyprus and United States rank globally for coverage of the human papillomavirus vaccine?
- Cyprus ranks 45th and United States ranks 48th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.